Skip to content

Member Login

Alzheimer's Disease Sequencing Project

Home
About
Funded Programs
Data
Research
FAQ
News
Member Login

Correction to: BMI1 is associated with CSF amyloid-β and rates of cognitive decline in Alzheimer’s disease.

Post navigation

Previous: Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer’s disease.

Next: Murine roseolovirus does not accelerate amyloid-β pathology and human roseoloviruses are not over-represented in Alzheimer disease brains.

ADSP Footer

About

ADSP on NIA
Acknowledgment Statement
ADSP Follow-Up Study (FUS)
Contact

Research Tools

GenomicsDB
VariXam

Cohort Recruitment

READD
ACAD
NIA-AD FBS

© 2021 - 2025 University of Pennsylvania, School of Medicine. All rights reserved.

Home
About
Funded Programs
Data
Research
FAQ
News
Member Login